Evidence map›Paper›PMID 34816072›Full record

ArticleTranslational medicine of aging2021

Heart failure risk remote monitoring program in the very elderly patients with COVID-19 disease.

Abrar-Ahmad Zulfiqar, Emmanuel Andres, Mohamed Hajjam, Delwendé Noaga Damien Massimbo, Amir Hajjam

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Translational medicine of aging, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Abrar-Ahmad ZulfiqarService de Médecine Interne, Diabète et Maladies métaboliques de la Clinique Médicale B, Hôpitaux Universitaires de Strasbourg et Equipe EA 3072 "Mitochondrie, Stress oxydant et Protection musculaire", Faculté de Médecine, Université de Strasbourg, 67000, Strasbourg, France.
Emmanuel AndresService de Médecine Interne, Diabète et Maladies métaboliques de la Clinique Médicale B, Hôpitaux Universitaires de Strasbourg et Equipe EA 3072 "Mitochondrie, Stress oxydant et Protection musculaire", Faculté de Médecine, Université de Strasbourg, 67000, Strasbourg, France.
Mohamed HajjamPredimed Technology, 67300, Schiltigheim, France.
Delwendé Noaga Damien MassimboPredimed Technology, 67300, Schiltigheim, France.
Amir HajjamLaboratoire IRTES-SeT, Université de Technologie de Belfort-Montbéliard (UTBM), Belfort-Montbéliard, Belfort, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19 diseaseGer-e-Tec COVID studyHeart failure riskMyPredi platformTelemonitoring

Identifiers

PMID34816072
PMCPMC8598265

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.